did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

We're the #1 textbook rental company. Let us show you why.

9781118353240

Pharmacogenomics of Human Drug Transporters Clinical Impacts

by ; ;
  • ISBN13:

    9781118353240

  • ISBN10:

    1118353242

  • Edition: 1st
  • Format: eBook
  • Copyright: 2013-03-18
  • Publisher: Wiley
  • Purchase Benefits
  • Free Shipping Icon Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • eCampus.com Logo Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $160.00
We're Sorry.
No Options Available at This Time.

Summary

Sets the foundation for safer, more effective drug therapies

With this book as their guide, readers will discover how to apply our current understanding of the pharmacogenomics of drug transporters to advance their own drug discovery and development efforts. In particular, the book explains how new findings in the field now enable researchers to more accurately predict drug interactions and adverse drug reactions. Moreover, it sets the foundation for the development of drug therapies that are tailored to an individual patient's genetics.

Pharmacogenomics of Human Drug Transporters serves as a comprehensive guide to how transporters regulate the absorption, distribution, and elimination of drugs in the body as well as how an individual's genome affects those processes. The book's eighteen chapters have been authored by a team of leading pioneers in the field. Based on their own laboratory and clinical experience as well as a thorough review of the literature, these authors explore all facets of drug transporter pharmacogenomics, including:

  • Individual drug transporters and transporter families and their clinical significance
  • Principles of altered drug transport in drug–drug interactions, pharmacotherapy, and personalized medicine
  • Emerging new technologies for rapid detection of genetic polymorphisms
  • Clinical aspects of genetic polymorphisms in major drug transporter genes
  • Future research directions of drug transporter pharmacogenomics and the prospect of individualized medicine

Pharmacogenomics of Human Drug Transporters opens the door to new drug discovery and development breakthroughs leading to safer and more effective customized drug therapies.The book is recommended for pharmaceutical scientists, biochemists, pharmacologists, clinicians, and genetics and genomics researchers.

Author Biography

TOSHIHISA ISHIKAWA, PhD, is Senior Scientist at RIKEN Yokohama Institute and Professor of Biochemistry, Molecular Biology, and Pharmacogenomics at Yokohama City University's Graduate School of Medicine. Previously, Dr. Ishikawa was the Director of the Department of Research Technology Development at Pfizer, Japan. A recipient of the Achievement Award from the International Life Sciences Institute (ILSI), Dr. Ishikawa is also the cofounder of the International Transporter Consortium (ITC).

RICHARD B. KIM, MD, FRCPC, is Professor and Chair of the Division of Clinical Pharmacology and Associate Chair for Research in the Department of Medicine at the University of Western Ontario. He is a Fellow of the American Association of Pharmaceutical Scientists and an elected member of the American Society for Clinical Investigation.

JÖRG KÖNIG, PhD, is Professor and Head of the Molecular Biology Laboratories in the Department of Clinical Pharmacology at the Friedrich-Alexander Universität Erlangen-Nürnberg.

Table of Contents

Preface

Contributors

Chapter 1: Introduction to pharmacogenomics of drug transporters
Marianne K DeGorter and Richard B Kim

Chapter 2: ADME Pharmacogenomics in Drug Development
Liangfu Chen and Joseph W. Polli

Chapter 3: Regulatory Perspective on Pharmacogenomics of Drug Metabolizing Enzymes and Transporters
Lei Zhang, Gilbert J. Burckart, Shiew-Mei Huang and Lawrence J. Lesko

Chapter 4: The Pharmacogenomics of Membrane Transporters Project
Sook Wah Yee, Deanna L. Kroetz and Kathleen M. Giacomini

Chapter 5: Emerging new technology of SNP typing
Toshihisa Ishikawa and Yoshihide Hayashizaki

Chapters 6: OATP1A2, OAT1 and OAT3
Rommel G. Tirona

Chapter 7: OATP1B1, OATB1B3 and OATP2B1
Jörg König and Martin Fromm

Chapter 8: OCT (SLC22A) and OCTN Families
Sophie L. Stocker, Kathleen M. Giacomini, Arian Emami-Riedmaier and A. Matthias Schwab

Chapter 9: MATE (SLC47) Family

Atsushi Yonezawa andKen-ichi Inui

Chapter 10: PEPT (SLC15A) Family
Tomoko Sugiura, Saki Umeda, Akira Tsuji and Yukio Kato

Chapter 11: Nucleoside Transporters (SLC28 and SLC29) Family
Míriam Molina-Arcas and Marçal Pastor-Anglada

Chapter 12: P-Glycoprotein (MDR1/ABCB1)
Ingolf Cascorbi

Chapter 13: Bile Salt Export Pump BSEP (ABCB11): Role in Liver Physiology and Liver Disease
Gerd Ullak-Kublick and Bruno Stieger

Chapter 14: BCRP (ABCG2)
Agnes Basseville, Susan E. Bates, William D. Figg and Alex Sparreboom

Chapter 15: MRP2 (ABCC2) and MRP3 (ABCC3)
Anne T. Nies

Chapter 16: MRP4 (ABCC4)
Satish B.Cheepala, Mugdha Sukthankar and John D. Schuetz

Chapter 17: MRP8 (ABCC11)
Yu Toyoda and Toshihisa Ishikawa

Chapter 18: Future Perspectives
Toshihisa Ishikawa and Joseph Ware

Index

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Rewards Program